Cargando…
Clinical-based Cell Therapies for Heart Disease—Current and Future State
Patients have an ongoing unmet need for effective therapies that reverse the cellular and functional damage associated with heart damage and disease. The discovery that ~1%–2% of adult cardiomyocytes turn over per year provided the impetus for treatments that stimulate endogenous repair mechanisms t...
Autores principales: | Turner, Darren, Rieger, Angela C., Balkan, Wayne, Hare, Joshua M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202446/ https://www.ncbi.nlm.nih.gov/pubmed/32374254 http://dx.doi.org/10.5041/RMMJ.10401 |
Ejemplares similares
-
Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020) -
The Future of Stroke Interventions
por: Abergel, Eitan
Publicado: (2020) -
Coronary Stenosis Physiology and Novel Technologies
por: Pravda, Nili Schamroth, et al.
Publicado: (2020) -
CPR and ECMO: The Next Frontier
por: Ambinder, Daniel I., et al.
Publicado: (2020) -
New Insights into Valve Hemodynamics
por: Marom, Gil, et al.
Publicado: (2020)